VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 732 filers reported holding VANECK VECTORS ETF TR in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,671 | -10.6% | 1,883 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $56,697 | -6.9% | 1,883 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $60,915 | +12.9% | 1,883 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $53,966 | -99.9% | 1,883 | 0.0% | 0.01% | +12.5% |
| Q3 2022 | $45,417,000 | -11.9% | 1,883 | 0.0% | 0.01% | -11.1% |
| Q2 2022 | $51,556,000 | -28.6% | 1,883 | 0.0% | 0.01% | -18.2% |
| Q1 2022 | $72,213,000 | +19.7% | 1,883 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $60,312,000 | +8.7% | 1,883 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $55,492,000 | -13.3% | 1,883 | 0.0% | 0.01% | -18.2% |
| Q2 2021 | $63,984,000 | +4.6% | 1,883 | 0.0% | 0.01% | -8.3% |
| Q1 2021 | $61,197,000 | -9.8% | 1,883 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $67,825,000 | -13.3% | 1,883 | -11.7% | 0.01% | -22.2% |
| Q2 2020 | $78,238,000 | -75.0% | 2,133 | -84.3% | 0.02% | -80.6% |
| Q1 2020 | $313,528,000 | – | 13,608 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |